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Over the past several years, the molecular 
mechanisms governing Th1 diff  erentiation have 
led to the identifi  cation of two major Th1-
  related signaling pathways, one involving IL-
12/STAT4 (1–11) and the other involving 
IFN-γ/STAT1/T-bet (8–11). Of these, the 
latter or T-bet pathway has been assumed to be 
the most important because T-bet–  defi  cient 
mice (T-bet−/− mice) cannot mount Th1   re-
sponses, and retroviral expression of T-bet in 
developing and/or developed Th2 cells not 
only induces IFN-γ production, but also 
  suppresses IL-4 and IL-5 production (10, 11). 
Moreover, such eff   ects of T-bet have been 
  argued to be at least partially independent of 
STAT4 because under certain stimulation con-
ditions retroviral expression of T-bet in devel-
oping Th1 cells derived from STAT4-defi  cient 
mice has been shown to support IFN-γ syn-
thesis (9, 12). Finally, evidence has been ad-
duced with the use of in vitro reporter assays 
and retroviral constructs expressing T-bet or a 
dominant-negative form of T-bet that this tran-
scription factor is essential for early acquisition 
of accessibility at the IFNG promoter (9, 13). 
Thus, a symmetrical model has been put forth 
in which T-bet and GATA-3 function early in 
Th development to regulate IFNG and IL-4/
IL-5 gene expression, respectively. The cyto-
kines  IL-12 and IL-4/IL-5 function second-
arily,   acting via STATs to promote cell growth 
and extinguish expression of either GATA-3 
or T-bet (14).
However, recent data argue against this 
model. First, Afkarian et al. (12) reported that 
retroviral T-bet expression in Th2 cells  induced 
only low amounts of IFN-γ, failed to suppress 
Th2 cytokines when the cells were stimulated 
under more “physiological  conditions” (antigen 
plus APCs), and induced only relatively small 
amounts of IFN-γ when the cells were stimu-
lated with pharmacologic agents (PMA/ionomy-
cin). Second, we and Afkarian et al. reconfi  rmed 
that STAT4−/− Th cells mount a defective Th1 
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response when they are stimulated by Con A/APCs or antigen 
(OVA)/APCs (12, 15). Finally, we recently   reported that devel-
oping Th2 cells from T-bet−/− mice could   diff  erentiate into Th1 
cells when STAT4 and IL-12Rβ2 chain expression are main-
tained (16). These data supporting the importance of STAT4 
signaling in Th1 diff  erentiation are thus in general agreement 
with our previous studies showing that GATA-3 suppresses Th1 
development through down-regulation of STAT4 rather than 
through inhibition of T-bet or the IL-12Rβ2 chain, and that 
the   maintenance of STAT4 expression overcomes the eff  ect of 
GATA-3 in developing Th2 cells.
Based on the uncertainties described above concerning 
Th diff   erentiation, we conducted studies of cells from 
T-bet−/− mice to better defi   ne the relation of T-bet to 
GATA-3, STAT4, and other key factors. These studies show 
that an essential, nonredundant function of T-bet in devel-
oping Th1 cells is to antagonize GATA-3 expression and/or 
function that would otherwise abort Th1 diff  erentiation, 
and that T-bet does not have an early, obligate role in chro-
matin remodeling and/or transcription of the IFNG gene.
RESULTS
Elevated IL-4 and GATA-3 in committed Th2 cells 
of T-bet−/− mice
In initial studies, we compared the ability of whole CD4+ 
T cells and naive (CD4/CD62Lhigh) T cells from T-bet+/−, 
T-bet−/−, and wild-type mice to undergo Th1/Th2 dif-
ferentiation in vitro under the Th1 conditions ordinarily 
encountered in vivo (IL-12 only and no anti–IL-4 anti-
body). As shown in Fig. 1 A, the percentages of Th1 cells 
were high and Th2 cells were low in cell cultures of both 
whole CD4+ T cells and naive T cells of wild-type mice, 
whereas comparable T cell populations from T-bet−/− 
mice exhibited marked Th2 diff  erentiation,  particularly 
when whole CD4+ T cells were studied. These data sug-
gest that many CD4+ T cells in T-bet−/− as well as in 
T-bet+/− mice are precommitted to Th2 cell diff  erentia-
tion in vivo.
We next determined the capacity of naive CD4+ T cells 
from wild-type and T-bet−/− mice to produce IFN-γ and 
IL-4 after primary stimulation. As shown in Fig. 1 B, we 
found that naive CD4+ T cells from T-bet−/− mice secreted 
seven and four and one half times more IL-4 than similar cells 
from wild-type mice when cultured under neutral and sub-
optimal Th1 conditions (defi  ned here and below as IL-12 in 
the absence of anti–IL-4 antibody), respectively. In addition, 
as shown also in Fig. 1 B, although T-bet+/+ cells produced 
considerably more IFN-γ than T-bet−/− cells, particularly in 
the presence of IL-12 signaling, T-bet−/− cells were none-
theless able to produce substantial amounts of this cytokine. 
One interpretation of these data are that naive T-bet−/− 
CD4+ T cells can be characterized as cells with low respon-
siveness to IL-12 rather than as cells that are intrinsically 
  unable to produce IFN-γ.
Figure 1.  Elevated IL-4 and GATA-3 and committed Th2 cells in 
T-bet−/− mice. (A) Naive CD4+ T cells and whole CD4+ T cells from T-bet−/−, 
T-bet+/+, and wild-type mice were stimulated with anti-CD3/anti-CD28 
and maintained under Th1 conditions (IL-12 only) and expanded with IL-2. 
On day 6, the cells were subjected to intracellular cytokine staining after 
restimulation with PMA/ionomycin. These data are representative of results 
obtained from three independent experiments. (B) Naive CD4+ T cells from 
T-bet−/− and wild-type mice were stimulated with anti-CD3/anti-CD28 
under Th1 conditions (IL-12 only) or neutral (no cytokines or antibodies 
added) conditions for 48 h, and then culture supernatants were harvested 
for IFN-γ and IL-4 determination by ELISA. The data shown are averages 
± SE derived from three independent experiments. (C) Naive CD4+ T cells 
from T-bet−/− and wild-type mice were stimulated with anti-CD3/
anti-CD28 under Th1 conditions (IL-12 only) or neutral conditions and 
maintained for the time periods shown in the fi  gure. At each time point, 
cells were harvested and total RNAs were isolated and subjected to 
real-time PCR analysis for GATA-3 mRNA quantifi  cation. Independently, 
total RNAs from freshly isolated naive and memory CD4+ T cells were 
prepared for day 9 samples. The data shown are averages ± SE derived 
from three independent experiments.JEM VOL. 203, March 20, 2006  757
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In related studies, we measured the kinetics of GATA-3 
mRNA production in CD4+ T cells stimulated with 
anti-CD3/anti-CD28 under neutral or suboptimal Th1 con-
ditions as defi  ned above. As shown in Fig. 1 C, T-bet−/− 
CD4+ T cells initially displayed a slightly increased level of 
GATA-3 mRNA level (measured by real-time RT-PCR) 
as compared with wild-type cells; however, under either 
neutral or suboptimal Th1 conditions, GATA-3 mRNA 
levels decreased over time in wild-type cells, whereas these 
levels steadily increased under neutral conditions and only 
slightly declined under suboptimal Th1 conditions in 
T-bet−/− cells. Furthermore, T-bet−/− eff  ector–memory 
CD4+ T cells (cells stimulated under neutral conditions and 
then studied after 9 d of culture) displayed markedly elevated 
GATA-3 mRNA levels as compared with wild-type cells. 
These data indicate that naive T-bet−/− CD4+ T cells under 
neutral or suboptimal Th1 conditions do not suppress GATA-3 
as do wild-type cells.
T-bet–independent Th1 development and 
IL-12R𝗃2 chain expression
The data described above suggest that the defective Th1 
response in T-bet−/− mice would be due to a constitutive 
increase of GATA-3 levels. Because a major regulator of 
GATA-3 is IL-4, we next considered whether the defective 
Th1 response in T-bet−/− mice could be altered by neutral-
ization of endogenous IL-4 by anti–IL-4 antibody; i.e., when 
cells are stimulated under optimal Th1 conditions (defi  ned 
here and below as IL-12 plus anti–IL-4 antibody). To test this 
possibility, naive CD4+ T cells from T-bet−/− and wild-type 
Figure 2.  T-bet–independent Th1 development and IL-12R𝗃2 chain 
expression. (A) Naive CD4+ T cells from T-bet−/− and wild-type mice 
(purifi  ed by fl  ow cytometric sorting) were stimulated with Con A/APC (30 Gy-
irradiated splenocytes from wild-type mice) under optimal Th1 conditions 
(IL-12 + anti–IL-4), suboptimal Th1 conditions (IL-12 only or anti–IL-4 only), 
neutral conditions, or suboptimal Th2 (IL-4 only) conditions. The cells were 
then expanded with IL-2 as well as cytokines and antibodies on days 2 and 4. 
On day 8, the cells were restimulated by PMA/ionomycin and subjected to 
intracellular cytokine staining for IL-4 and IFN-γ. See Materials and methods 
for further details. (B) Experimental design was the same as in A, except that 
cells subject to two kinds of stimulation (Con A/APC and anti-CD3/anti-
CD28) were compared. These data are representative of results obtained from 
three independent experiments. (C) Naive CD4+ T cells from T-bet−/− and 
wild-type mice (purifi  ed by fl  ow cytometric sorting) were stimulated with 
anti-CD3/anti-CD28 in the presence of IL-12 and 20 μg/ml anti–IL-4 (for opti-
mal Th1 conditions) or with 5 ng/ml IL-12 (for suboptimal Th1 conditions). 
The cells were expanded by the addition of IL-2 on day 4 of culture and then 
washed and restimulated with PMA/ionomycin or plate-bound (pb) anti-CD3 
on day 6, and culture supernatants were collected after 6 and 24 h, 
  respectively, for assay of IFN-γ by ELISA (See Materials and methods).758  T-BET-INDEPENDENT TH1 DEVELOPMENT | Usui et al.
mice were isolated as described in Materials and methods and 
stimulated with Con A plus APCs under optimal or subopti-
mal Th1 conditions, as well as under neutral or Th2 condi-
tions (the latter consisting of cultures containing IL-4 only). 
On day 4, surface expression of IL-12Rβ2 chain was mea-
sured by fl  ow cytometry, and on day 7, cytokine production 
was measured by intracellular cytokine staining. As shown in 
Fig. 2 (A and B), the percentage of cells displaying IFN-γ 
production obtained in cultures of naive T-bet−/− CD4+ 
cells stimulated under optimal Th1 conditions was quite 
comparable to that seen in wild-type cells, whereas, under 
suboptimal Th1 conditions, very few Th1 cells appeared. 
Similarly, as shown in Fig. 2 B, comparable results were 
  obtained in cell cultures in which plate-bound anti-CD3/
soluble anti-CD28 was the initial stimulus. Furthermore, as 
shown in Fig. 2 C, secretion of IFN-γ into the culture 
supernatant by naive T-bet−/− CD4+ T cells (in this case, 
CD44lo/CD62Lhi cells obtained by cell sorting) was equiva-
lent to that of wild-type cells under optimal Th1 conditions 
but not   under suboptimal conditions. In this case, IFN-γ 
  secretion was measured after initial stimulation of cells by 
anti-CD3/soluble anti-CD28 for 6 d followed by restim-
ulation with  either plate-bound anti-CD3/soluble anti-CD28 
for 48 h or PMA and ionomycin for 24 h. These studies 
  indicate that T-bet−/− cells and wild-type cells stimulated 
under optimum Th1 conditions are equivalent with respect 
to IFN-γ   production when evaluated either by the num-
ber of cells   expressing IFN-γ or by the secretion of IFN-γ 
over a period of time. Finally, as shown in Fig. S1 (available at 
http://www. jem. org/cgi/content/full/jem. 20052165/ DC1), 
  although T-bet−/− cells cultured under optimal conditions 
expressed virtually normal levels of IL-12Rβ2, those cultured 
under suboptimal Th1, neutral, or Th2 conditions expressed 
low levels of IL-12Rβ2. Overall, the results described above 
lead to the conclusion that naive T-bet−/− cells diff  erentiate 
into Th1 cells and express IL-12Rβ2 chain quite normally 
under optimal Th1 conditions in which GATA-3 induction 
is limited by blockade of IL-4 activity.
Accessibility of the IFNG promoter in T-bet−/− cells
Previous studies based on the use of T-bet–expressing retro-
viruses have led to the view that T-bet is an obligate regu-
lator of IFNG promoter remodeling (9, 13, 14). In light of 
the results obtained above showing that T-bet−/− cells can 
produce IFN-γ provided that GATA-3 levels are controlled 
by blockade of IL-4R/STAT6 signaling with anti–IL-4, we 
next reexamined the relation of T-bet to IFNG promoter 
  remodeling (accessibility) by assessing IFNG promoter his-
tone acetylation using the chromatin immunoprecipitation 
(ChIP) assay. In these studies, naive spleen cells were   obtained 
from T-bet−/− and wild-type mice, stimulated with anti-
CD3/anti-CD28 under suboptimal (IL-12 in the absence of 
anti–IL-4) or optimal (IL-12 in the presence of anti–IL-4) 
Th1 conditions for 3 d, and then processed for ChIP assay 
(see Materials and methods). As shown in Fig. 3 A, T-bet−/− 
cells stimulated under suboptimal Th1 conditions and, as 
shown above, exhibiting little IFN-γ production displayed 
little or no histone acetylation at the H3 site, whereas 
T-bet+/+ cells displayed a strong acetylation signal. In con-
trast, T-bet−/− cells stimulated under optimal Th1 conditions 
and exhibiting virtually normal IFN-γ production also dis-
played a strong acetylation signal.
We confi  rmed these results by analyzing DNase hyper-
sensitivity of the IFNG locus. As shown in Fig. 3 B, the locus 
is readily accessible to digestion when wild-type cells are 
  incubated under optimal or suboptimal conditions, but not 
under neutral conditions. In contrast, the IFNG locus is 
Figure 3.  T-bet−/− cells cultured under optimal Th1 conditions 
(in the presence of anti–IL-4) display normal IFNG promoter accessi-
bility (histone acetylation). (A) Naive CD4+ T cells from T-bet+/+ and 
T-bet−/− mice were stimulated with anti-CD3/anti-CD28 under suboptimal 
(IL-12) or optimal (IL-12 plus anti–IL-4) Th1 conditions. After 3 d, the cells 
were subjected to ChIP assay as described in Materials and methods. 
Ig, isotype control H3, α-acetyl-histone 3. (B) DNase I hypersensitivity 
pattern of the IFNG locus of wild-type naive T cells stimulated with 
anti-CD3/anti-CD28 and cultured under optimal, suboptimal, or neutral 
conditions for 6 d. Hypersensitivity sites I and II are indicated by arrows. 
(C) Comparison of DNase I hypersensitivity patterns of the IFNG locus in 
wild-type and T-bet−/− naive CD4+ T cells cultured under optimal or   optimal 
conditions for 6 d. Hypersensitivity sites I and II are indicated by arrows.JEM VOL. 203, March 20, 2006  759
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  sensitive to digestion when T-bet–defi  cient cells are cultured 
under optimal conditions but is less evident under suboptimal 
conditions. Collectively, the ChIP assay and the DNase I 
analysis provide strong evidence that IFNG promoter acces-
sibility can proceed in the absence of T-bet under optimal 
Th1 conditions. As such, these data are consistent with the 
data reported above relating to IFN-γ production under 
these conditions.
STAT4 signaling is impaired in T-bet−/− CD4+ T cells
Because in previous studies we have shown that elevated 
GATA-3 levels are associated with decreased STAT4 expres-
sion and unresponsiveness to IL-12 in wild-type cells (16), 
we next examined if the same were true in T-bet−/− cells. 
Accordingly, we determined STAT4 protein levels by Western 
blot in wild-type and T-bet−/− cells at various times after 
stimulation. As shown in Fig. 4 (A and B), on day 0, naive 
T-bet−/− CD4+ T cells expressed slightly lower amounts of 
STAT4 protein than wild-type cells, and on day 2, this 
  diff  erence was more pronounced and was observed under 
both suboptimal Th1 and neutral conditions. Finally, on day 7, 
both total STAT4 and phosphorylated STAT4 protein
were decreased in T-bet−/− CD4+ T cells, especially under 
suboptimal Th1 conditions. Similar fi  ndings have recently 
been reported by Underhill et al. (17). On the other hand, 
phosphorylated STAT4 was present in normal amounts in 
T-bet−/− cells stimulated in the presence of anti–IL-4 anti-
body, probably because IL-12Rβ2 chain expression is main-
tained under these conditions (Fig. S1). Finally, we detected 
GATA-3 protein only in T-bet−/− T cells that were main-
tained under suboptimal Th1 conditions (not depicted).
The fi  ndings described above led to studies of naive CD4+ 
T-bet−/− cells in which STAT4 levels were maintained by 
a STAT4-expressing retrovirus. As shown in Fig. 4 (C and D), 
maintenance of STAT4 levels using this approach restored 
Th1 diff  erentiation very eff  ectively, even under suboptimal 
Th1 conditions, and this eff  ect was associated with the down-
regulation of GATA-3. These data indicate that the main-
tenance of STAT4 expression is enough to rescue Th1 
development in T-bet−/− T cells (despite the reduction 
In IL-12Rβ2 expression; Fig. 2 B). As such, they comple-
ment the results shown in Fig. 2 A, in that we again saw a 
virtual normalization of IFN-γ production in T-bet−/− cells
under conditions in which GATA-3 eff  ects are obviated.
Retroviral T-bet expression suppresses GATA-3 
and Th2 cytokines
Szabo et al. (10) suggested earlier that T-bet eff  ects on Th2 
cytokine production may in part result from its ability to sup-
press GATA-3 expression. However, this was not directly 
examined. To examine this question, we fi  rst determined the 
eff  ect of retroviral T-bet expression on GATA-3 expression 
Figure 4.  STAT4 signaling is impaired in T-bet−/− CD4+ T cells. 
(A) Naive CD4+ T cells from T-bet−/− and wild-type mice were stimulated with 
anti-CD3/anti-CD28 under either suboptimal Th1 conditions (IL-12 only) or 
neutral conditions. After maintenance for the time periods shown in the 
fi  gure, whole cell lysates were subjected to Western blot analysis. Indepen-
dently, lysates from freshly isolated naive CD4+ T cells were prepared for 
day 0 samples. Similar results were obtained in three other independent 
experiments. (B) Naive CD4+ T cells from T-bet−/− and wild-type mice were 
stimulated with anti-CD3/anti-CD28 under either optimal Th1 conditions 
(IL-12 + anti–IL-4) or suboptimal Th1 conditions (IL-12 only), and then 
expanded with IL-12 as well as cytokines and antibodies on days 2 and 4. 
On day 7, the cells were restimulated with fresh IL-12 for 30 min and lysed 
for Western blot analysis. Recombinant GATA-3 protein was prepared from 
GATA-3–expressing retrovirus-transfected Phoenix-Eco packaging cell line. 
Similar results were obtained in three other independent experiments. 
(C) Naive CD4+ T cells from T-bet−/− mice were stimulated and maintained as 
described in B. On day 2, the cells were infected with either control retro  virus 
(GFP-RV) or STAT4-expressing retrovirus (STAT4-RV). On day 7, the cells were 
restimulated by PMA/ionomycin and subjected to intracellular cytokine 
staining for IL-4 and IFN-γ. (D) The cells used in C were sorted by a fl  ow 
cytometer according to GFP expression on day 6 and then lysed for Western 
blot analysis. The lysate of the Th2 line from T-bet−/− mice was also prepared 
as a positive control for GATA-3 protein. These data are representative of 
those obtained in three independent experiments.760  T-BET-INDEPENDENT TH1 DEVELOPMENT | Usui et al.
in developing Th2 cells; i.e., in cells naturally expressing 
GATA-3. Naive CD4+ T cells from either T-bet−/− or wild-
type mice were stimulated and maintained under optimal 
Th2 conditions (IL-4 plus anti–IL-12) and then infected with 
a mock or T-bet–expressing retrovirus on day 2. On day 7, 
GFP+ cells were obtained by fl  ow cytometric sorting and 
subjected to Western blot analysis. As shown in Fig. 5 A, it 
was clear that GATA-3 protein expression was shut down 
  almost completely in cells that expressed retroviral T-bet. We 
next examined the eff  ect of retroviral infection on develop-
ing Th1 cells from T-bet−/− and wild-type mice with retro-
viruses expressing STAT4, IL-12Rβ2 chain, or T-bet on the 
percentages of IL-4–producing cells. As shown in Fig. 5 B (as 
well as Fig. 2, A and C), low but clearly increased percentages 
Figure 5.  T-bet overexpression suppresses GATA-3 and Th2 
  cytokines. (A) Naive CD4+ T cells from T-bet−/− and wild-type mice 
were stimulated with anti-CD3/anti-CD28 under strict Th2 conditions 
(IL-4 + anti–IFN-γ + anti–IL-12). On day 2, the cells were infected with 
control (mock) or T-bet–expressing retrovirus (T-bet-RV). Finally, on day 7, 
GFP+ cells were sorted by fl  ow cytometry and lysed for Western blot 
studies. These data are representative of those obtained in three inde-
pendent experiments. (B) Naive CD4+ T cells from T-bet−/− and wild-
type mice were stimulated with anti-CD3/anti-CD28 under optimal Th1 
conditions. On day 2, the cells were infected with control (mock) or 
STAT4-, IL-12Rβ2 chain–, or T-bet–expressing retroviruses. Finally, on 
day 7, cells were restimulated by PMA/ionomycin and subjected to intra-
cellular cytokine staining for IL-4. The values shown were the percent-
ages of IL-4+ cells in the GFP+ population. These data are representative 
of those obtained from two independent experiments. (C) An established 
murine Th2 cell line (D10 cells) was stimulated with conalbumin/APCs 
and then infected with a T-bet–expressing retrovirus on days 2, 3, 4, and 5. 
On day 14, GFP+ cells were enriched by fl  ow cytometric sorting and 
restimulated with antigen/APC. Finally, on day 21, GFP+ and GFP− cells 
were separated by sorting (purities were >92%) and lysed for Western 
blot analysis. (D) T-bet–expressing and nonexpressing D10 cells were 
obtained and cultured as described in C. On day 21, the cells were re-
stimulated with either high (2 μg/ml) or low (0.2 μg/ml) concentrations 
of plate-bound anti-CD3 and/or conalbumin/APCs. 48 h after such 
  restimulation, culture supernatants were collected and IL-4, IL-5, and 
IFN-γ were measured by ELISA. Similar results were obtained in three 
independent experiments. (E) T-bet–expressing and nonexpressing D10 
cells were obtained and cultured as described in C. On day 21, 2 μg/ml 
actinomycin D was added to the cultures, and cells were harvested every 
30 min for extraction of total RNA and subsequent real-time PCR analy-
sis for GATA-3 mRNA. The left panel depicts the relative amount of 
GATA-3 mRNA normalized by 18S rRNA, and the right panel depicts the 
percent decreases from the nontreated sample. Similar results were 
  obtained in two independent experiments.JEM VOL. 203, March 20, 2006  761
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of IL-4–producing cells (5–10%) were seen even in T-bet−/− 
cell populations that were maintained under optimal Th1 
conditions (IL-12 plus anti–IL-4 antibody). It is therefore 
very diffi     cult to completely block Th2 development in 
T-bet−/− Th1 cells. However, in the presence of IL-12, 
  retroviral T-bet expression could dramatically suppress the 
appearance of IL-4–producing cells (50- and 20-fold reduc-
tion in T-bet−/− and wild-type Th1 cells, respectively), but 
under the same conditions, retroviral IL-12Rβ2 chain 
  expression failed to do so and retroviral STAT4 expression 
had only a modest eff  ect. These data support our previous 
  report in which we showed that retroviral expression of 
IL-12Rβ2 chain cannot change the fate of Th1/Th2 diff  eren-
tiation, whereas retroviral expression of STAT4 can promote 
Th1   diff  erentiation and block Th2 diff  erentiation (15, 16).
In related studies, we examined the eff  ect of retroviral 
expression of T-bet on GATA-3 expression in a fully dif-
ferentiated D10 Th2 cell line. In the present study, we in-
fected D10 cells with a T-bet–expressing retrovirus, sorted 
the cells according to GFP expression, and subjected the 
positive cells obtained to Western blot analysis. As shown in 
Fig. 5 C, GATA-3 protein levels were clearly decreased in 
T-bet–  expressing D10 cells compared with noninfected, 
wild-type D10 cells. Then, using the same cells, we mea-
sured IL-4, IL-5, and IFN-γ secretion by ELISA under var-
ious conditions of restimulation. As shown in Fig. 5 D, 
retroviral expression of T-bet in D10 cells did not suppress 
IL-4 secretion when these cells were stimulated with high 
concentrations of anti-CD3 antibody (2 μg/ml), partially 
suppressed IL-4 when they were stimulated with low con-
centrations of anti-CD3 antibody (0.2 μg/ml), and com-
pletely suppressed IL-4 when they were stimulated under 
suboptimal Th1 conditions by antigen (conalbumin plus 
APC). IL-5, a cytokine whose synthesis is controlled by 
GATA-3 more directly than IL-4 (18), was suppressed to 
an even greater extent. Of interest, retroviral expression of 
T-bet in D10 cells led to only low-level production in IFN-γ, 
even when they were stimulated with high concentrations 
of anti-CD3. These data again suggest that the main func-
tion of T-bet is to suppress GATA-3 expression and is not 
suffi   cient to directly regulate the IFNG gene, at least at this 
stage of T cell diff  erentiation.
Finally, we examined the mechanism of GATA-3 sup-
pression by T-bet by measuring GATA-3 mRNA stability 
after treatment of the D10 cells expressing retroviral T-bet 
with actinomycin D. As shown in Fig. 5 E, although 
GATA-3 mRNA levels in untreated T-bet–expressing D10 
cells were suppressed to about half of the level found in the 
wild-type cells, the   kinetics of degradation of GATA-3 
mRNA was similar in T-bet–expressing and nonexpressing 
D10 cells. These results suggest that T-bet suppresses 
GATA-3 at a transcriptional level rather than at a posttran-
scriptional level. However, it should be noted that some 
posttranslational control may also exist   because the down-
regulation of GATA-3 by T-bet is more evident at the pro-
tein level than it is at the mRNA level.
T-bet is not an essential factor for IL-12R𝗃2 
chain expression
Another possible role of T-bet in T cell diff  erentiation is the 
induction of IL-12Rβ2 chain. Although Afkarian et al. (12) 
suggested that T-bet is a suffi   cient factor for IL-12Rβ2 chain 
expression, our present data shown in Fig. S1 suggested that 
this is not in fact the case. To address this discrepancy further, 
we fi  rst measured IL-12Rβ2 chain expression in retroviral 
T-bet–expressing D10 cells that were used in the studies 
  described above. As shown in Fig. 6 A, IL-12Rβ2 chain 
  expression was induced even in fully diff  erentiated Th2 cells 
expressing retroviral T-bet, consistent with the data previously 
provided by Afkarian et. al. However, when we measured 
IL-12Rβ2 chain expression in developing Th1 cells, i.e., 
  naive CD4+ T cells from either T-bet−/− or wild-type mice 
stimulated under optimal Th1 conditions, a diff  erent pic-
ture emerged. As shown in Fig. 6 B, we observed normal 
IL-12Rβ2 chain expression in mock retrovirus–infected 
Figure 6.  T-bet is not a direct inducer of IL-12R𝗃2 chain. (A) T-bet–
expressing and nonexpressing D10 cells were obtained and cultured as 
described in Fig. 4 C and harvested for IL-12Rβ2 chain staining on day 21. 
The values shown in each panel depict the ∆ mean fl  uorescence inten-
sities (MFI)s for the IL-12Rβ2 chain stain after subtraction of the MFIs of 
a control stain. Open histograms depict isotype controls, and fi  lled histo-
grams depict IL-12Rβ2 chain–specifi  c staining. (B) Naive CD4+ T cells 
from T-bet−/− and wild-type mice were stimulated with Con A/APCs 
  under optimal Th1 (IL-12 + anti–IL-4) or Th2 conditions. On day 2, the 
cells were infected with control (mock), STAT4-, or T-bet–expressing retro-
viruses, and on day 5, surface IL-12Rβ2 chain staining was performed. 
The values shown in each panel represent the ∆MFIs of IL-12Rβ2 chain 
  expression in either GFP− or GFP+ populations after subtraction of the 
MFIs of control stainings.762  T-BET-INDEPENDENT TH1 DEVELOPMENT | Usui et al.
T-bet−/− Th1 cells, but neither retroviral T-bet expression 
in wild-type T cells nor retroviral T-bet maintenance in 
T-bet−/− Th1 cells led to IL-12Rβ2 chain expression. On 
the contrary, under these conditions, IL-12Rβ2 expression 
was suppressed compared with mock retrovirus–infected 
cells. Furthermore, we found that cells expressing retroviral 
STAT4 exhibited a higher level of IL-12Rβ2 chain expres-
sion in both Th1 cells from T-bet+/+ and T-bet−/− 
mice, with only slightly greater expression of the IL-12Rβ2 
chain in the T-bet−/− cells. Finally, IL-12Rβ2 chain expres-
sion was severely reduced in developing Th2 cells from 
T-bet−/− mice. These data strongly suggest that the initial 
expression of IL-12Rβ2 chain is induced by TCR stimula-
tion alone independently of T-bet and is negatively regulated 
by GATA-3 (and positively regulated by STAT4). The fi  nd-
ings of Afkarian et al. are likely explained by an indirect eff  ect 
of T-bet on GATA-3 rather than a direct eff  ect of T-bet on 
the IL-12Rβ2.
T-bet is induced in cells expressing retroviral STAT4 even 
in the absence of STAT1 and IFN-γ signaling
The last question we considered was the relation of STAT4 
signaling to T-bet expression in Th1/Th2 diff  erentiation. In 
our initial studies along these lines, we determined T-bet 
expression during the conversion of developing Th2 cells 
into Th1 cells under the infl  uence of retrovirally expressed 
STAT4, using cells from both wild-type (BALB/c) and 
STAT1−/− mice (the latter because STAT1 has been reported 
to be a critical factor for T-bet induction; references 8 and 12). 
Accordingly, naive CD4+ T cells were isolated from wild-
type and STAT1−/− mice and stimulated with anti-CD3/
anti-CD28 under optimal Th2 conditions (IL-4 plus anti–
IL-12 plus anti–IFN-γ). On day 2, the cells were infected 
with mock or STAT4-expressing retroviruses, and on day 4, 
after extensive washing, the Th2 cells thus obtained were 
cultured under Th1 conditions (IL-12 plus anti–IL-4 anti-
body) for another 3 d. Finally on day 7, intra-cellular cyto-
kine staining and Western blot analysis of the sorted cell 
populations were performed. As we reported previously (16) 
and as shown in Fig. 7 A, the switch to Th1 conditions on 
day 4 did not result in the appearance of many IFN-γ–
  producing cells at day 7 in cells infected with a mock retro-
virus, indicating that only 4 d of polarization under Th2 
conditions were enough to establish a Th2 phenotype. 
In contrast, when cells (from both wild-type and STAT1−/− 
mice) were switched to Th1 conditions and infected with a 
retrovirus expressing STAT4, a large fraction of the devel-
oping Th2 cells was converted into IFN-γ–producing cells. 
Furthermore, as shown in Fig. 7 B, the wild-type and 
STAT1−/− cells undergoing Th2 to Th1 conversion and 
  expressing retroviral STAT4 contained normal levels of 
T-bet protein, and as shown in Fig. 7 C, the level of T-bet 
protein expression in cells expressing retroviral STAT4 in-
creases with the strength of the IL-12/STAT4 signal. These 
data demonstrate that IL-12/STAT4 signaling can induce 
T-bet expression by a STAT1-independent mechanism.
In further studies addressing T-bet expression in cells not 
infected with a retrovirus expressing STAT4 (but expressing 
endogenous STAT4), we showed that in cells from 
STAT1−/−, IFN-γ−/−, and IFN-γR−/− mice, T-bet expres-
sion is increased in cells maintained under optimal Th1 con-
ditions as compared with cells maintained under suboptimal 
Th1 conditions, suggesting that STAT4 does indeed induce 
some T-bet expression independently of STAT1. It should 
be noted, however, that such signaling may not be quantita-
tively important because T-bet expression was decreased in 
STAT1−/− cells, especially if the latter are maintained in the 
absence of anti–IL-4 antibody (i.e., under optimal Th1 
  conditions), and STAT1 defi   ciency also leads to elevated 
IL-4/GATA-3 levels and decreased T-bet expression (not 
depicted). Therefore, we conclude that although at least some 
T-bet induction can occur in the absence of STAT1 signal-
ing, the latter is probably necessary for the optimal T-bet 
  induction in normal cells and thus for the regulation of 
GATA-3 in such cells.
DISCUSSION
The key fi  nding in this study was that T-bet−/− CD4+ T cells 
are in fact capable of producing virtually normal amounts of 
IFN-γ provided that one of two conditions are met: GATA-3 
accumulation is prevented by blockade of IL-4R signaling 
or GATA-3 negative regulation of STAT4 levels is bypassed 
by retroviral STAT4 expression. These results are seem-
ingly in confl  ict with previous studies by Szabo et al. (11) 
that showed that CD4+ T cells from T-bet−/− mice produce 
very low amounts of IFN-γ. However, this discrepancy can 
be   explained by the fact that in this study only naive CD4+ 
T cells were studied, whereas in the previous study such 
  preselection was not used. Naive cells must be used in these 
studies because as cells mature in vivo before being har-
vested for study they accumulate relatively high levels of 
GATA-3, especially in the absence of T-bet and, as shown 
in a previous study by Usui et al. (16), such GATA-3 can 
shut down STAT4 production and make it diffi   cult to induce 
Th1 polarization. Thus, to show that T-bet is not necessary 
for Th1 polarization, one must use highly purifi  ed  naive 
T cells. An additional reason for the discrepancy is that 
T-bet−/− cells grow less well in culture and produce less IFN-γ 
than wild-type cells unless cultured at a relatively high den-
sity. This condition was met in the studies of IFN-γ   secretion 
in the present study, but not in previous studies.
IFN-γ production in the absence of T-bet was accompa-
nied at the molecular level by histone acetylation and the 
  establishment of a DNase I hypersensitivity site in the IFNG 
promoter. These fi  ndings, along with observations showing 
that T-bet has only indirect eff   ects on IL-12Rβ2 chain 
  expression through its eff  ects on GATA-3, led us to the view 
that the main eff  ect of T-bet in developing Th1 cells is the 
suppression of GATA-3 levels or GATA-3 function. This 
view was supported by the additional fi  nding that retroviral 
T-bet expression down-regulates GATA-3 levels in developing 
Th2 cells and partially down-regulates GATA-3 protein JEM VOL. 203, March 20, 2006  763
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  levels in an established Th2 line. In previous studies con-
ducted by Mullen et al. (9, 13), it was shown that retroviral 
expression of T-bet in STAT4−/− cells (stimulated under 
Th2 conditions) led to the early appearance of a DNase I 
  hypersensitivity site in the IFNG gene promoter and retroviral 
expression of a dominant-negative T-bet construct in cells
(stimulated under Th1 conditions) blocked the appearance of 
this site. In contrast, in more quantitative studies conducted 
by Fields et al. (19), it was shown that retroviral expression of 
T-bet in STAT4−/− cells led to only a modest increase in 
histone acetylation, far lower than that seen in STAT4+/+ 
cells not expressing retroviral T-bet. In the present study we 
showed that histone H3 acetylation and DNase I hypersensi-
tivity sites of the IFNG promoter occurred in T-bet−/− cells 
provided that the cells were naive and stimulated under opti-
mum Th1 conditions (in the presence of anti–IL-4). These 
results indicate that the production of IFN-γ in T-bet–
  defi  cient cells is, in fact, accompanied by accessibility of the 
IFNG promoter and that such accessibility is not dependent 
on T-bet.
Despite this latter conclusion it remains possible that al-
though T-bet is not necessary for IFNG accessibility and 
transcription, it nevertheless takes part in this process in nor-
mal cells. In previous studies relevant to this possibility we 
showed that CD4+ T cells infected with both a retrovirus ex-
pressing STAT4 and GATA-3 exhibit normal IFN-γ pro-
duction under appropriate stimulation, whereas the same cells 
infected with retroviruses expressing T-bet and GATA-3 
  exhibit greatly reduced IFN-γ production (16). These fi  nd-
ings are most easily explained on the assumption that under 
conditions in which GATA-3 down-regulates STAT4, T-bet 
does not induce IFNG accessibility and transcription in and 
of itself. These previous fi  ndings, assuming that they apply to 
cells containing normal levels of STAT4, suggest that even 
when a normal level of T-bet is present within a developing 
Th1 T cell, it does not ordinarily exert an eff  ect on either 
IFNG accessibility or transcription. This conclusion is not 
necessarily at odds with reports that T-bet interacts with the 
promoter (or enhancers) of the IFNG gene (9, 13, 20–22) 
because these reports speak only to the potential for such 
  interaction and not to its actuality under normal conditions.
In their initial studies of T-bet, Szabo et al. (10) showed 
that T-bet suppresses IL-4 and IL-5 production in Th2 cells 
and suggested that such suppression occurred because T-bet 
inhibited GATA-3 activity. This view, however, was not 
supported in subsequent studies by Afkarian et al. (12), who 
found that cells stimulated under Th2 conditions and ex-
pressing retroviral T-bet exhibited normal GATA-3 expres-
sion by Western blot. In the present studies we provide 
evidence that in T cells newly diff  erentiating under optimal 
Th2 conditions, infection with a T-bet–expressing retrovirus 
has a profound inhibitory eff  ect on GATA-3 protein expres-
sion. Similarly, GATA-3 protein expression was down-
  regulated in an established Th2 cell line, the D10 cell line. 
Although data derived from studies in which factors are over-
expressed by retroviral infection must be interpreted with 
caution, it should be noted that in these studies levels of 
T-bet in Th2 cells infected with a retrovirus expressing T-bet 
did not greatly exceed that in developing Th1 cells; thus, the 
eff  ect of the T-bet–expressing retrovirus cannot be ascribed 
to overexpression per se. In studies using actinomycin D–
treated cells, we showed that T-bet at least partially medi-
ates an eff  ect on GATA-3 levels by exerting an eff  ect on 
Figure 7.  STAT4 signal induces T-bet in the absence of STAT1. 
(A) Naive CD4+ T cells from BALB/c and STAT1−/− mice were stimulated 
with anti-CD3/anti-CD28 under Th2 conditions for 4 d. 24 h after stimula-
tion, the cells were infected with mock-RV or STAT4-RV. On day 4, the cells 
were washed extensively and maintained under Th1 conditions (IL-12 and 
anti–IL-4 antibody) for another 3 d. Finally, the cells were restimulated by 
PMA/ionomycin and subjected to intracellular cytokine staining for IL-4 
and IFN-γ. Similar results were obtained in three independent experi-
ments. (B) The same cells used in A were initially cultured under Th2 con-
ditions for 4 d and then either cultured under Th1 conditions or 
continued under Th2 conditions for 3 d. The cells were then sorted on 
day 7 according to GFP expression to obtain cells expressing STAT4-RV 
and then lysed for Western blot analysis. Similar results were obtained in 
three independent experiments. (C) The same cells used in A were initially 
cultured under Th2 conditions for 4 d and then either cultured under Th1 
conditions with two concentrations of IL-12 or continued under Th2 con-
ditions for 3 d. The cells were then sorted on day 7 according to GFP ex-
pression to obtain cells expressing STAT4-RV or GFP-RV (mock) and then 
lysed for Western blot analysis. Similar results were obtained in three 
independent experiments. (D) Naive CD4+ T cells from C57BL/6, STAT1−/−, 
IFN-γ−/−, and IFN-γR−/− mice were stimulated with anti-CD3/anti-CD28 
either under strict Th1 conditions (IL-12 + anti–IL-4 antibody) or subop-
timal Th1 conditions (IL-12 only) and expanded by hu-IL-2. On day 7, 
these cell lines were lysed and subjected to Western blot analysis. Similar 
results were obtained in two independent experiments.764  T-BET-INDEPENDENT TH1 DEVELOPMENT | Usui et al.
GATA-3 transcription rather than an eff  ect on newly synthe-
sized GATA-3 mRNA. Another possibility not addressed in 
these studies is that T-bet aff  ects GATA-3 function as well as 
its level. Evidence for this possibility has recently come from 
Hwang et al. (23), who have shown that T-bet is phosphory-
lated by a Tec kinase (mainly ITK) early during Th1 diff  er-
entiation and the activated T-bet thus generated physically 
interacts with GATA-3 and prevents its binding to the IL-5 
promoter. Furthermore, these authors have shown that a 
mutation at Y525F that prevents phosphorylation at this site 
disables T-bet binding to GATA-3 and retroviral expression 
of the mutated protein in T-bet−/− cells was not eff  ective in 
repressing Th2 cytokine expression. Thus, T-bet might act 
on GATA-3 via multiple mechanisms.
It should be noted that in the present studies, although 
T-bet–expressing D10 cells produced less IL-4 and IL-5, 
such reduction was shown to be at least partially dependent 
on the strength of the TCR signal, indicating that the latter 
can override T-bet eff  ects by as yet unknown mechanisms. In 
addition, T-bet–expressing D10 cells produced only a small 
amount of IFN-γ (compared with normal Th1 cells). This 
result is consistent with earlier studies that showed that retro-
viral T-bet expression can only induce large amounts of IFN-γ 
production after stimulation of cells with a nonphysiological 
stimulus, PMA and ionomycin (12). Perhaps more impor-
tantly, it is also consistent with the view that T-bet is not an 
important transactivator of the IFNG promoter.
In additional studies, we addressed the relation between 
T-bet and IL-12Rβ2 chain expression. Previously, Afkarian 
et al. (12) reported that retroviral T-bet expression in devel-
oping Th2 cells induces IL-12Rβ2 chain expression, and, 
using a similar approach, we confi  rmed this result using a 
fully diff   erentiated Th2 clone. However, we found that 
  neither retroviral expression nor endogenous expression of 
T-bet led to IL-12Rβ2 expression in developing Th1 cells. 
This correlated with the fact that T-bet−/− cells expressed 
normal levels of IL-12Rβ2 chain under optimal Th1 condi-
tions, but expressed relatively low levels of IL-12Rβ2 chain 
under suboptimal Th1 conditions (IL-12 in the absence of 
anti–IL-4 antibody), in which case they produce large 
amounts of IL-4 and preferentially develop into Th2 cells. 
Although these data demonstrate that T-bet is not essential 
for IL-12Rβ2 chain expression, collectively with the data 
provided by Afkarian et al., they suggest that T-bet has an 
indirect infl  uence on such expression through its ability to 
obviate GATA-3 eff  ects on STAT4. Relevant to this last 
possibility, we show here that STAT4 signaling can induce 
IL-12Rβ2 chain expression in the absence of T-bet and have 
shown previously that GATA-3 down-regulation of the 
IL-12Rβ2 chain occurs through down-regulation of STAT4. 
The idea that T-bet aff  ects IL-12Rβ2 chain expression indi-
rectly via its eff  ects on GATA-3 is consonant with previous 
studies establishing the centrality of GATA-3 in Th2 diff  er-
entiation (24, 25).
Because GATA-3 is present in normal resting (naive) 
CD4+ cells even before activation (26, 27), the fi  ndings 
  described above suggest that STAT4 expression necessary for 
Th1 development requires early down-regulation of GATA-3 
levels or function early on, presumably by induction of 
T-bet. In the present studies we show that T-bet is expressed 
in STAT1−/− cells undergoing conversion from Th2 to Th1 
cells expressing retroviral STAT4, implying that in the pres-
ence of high levels of STAT4, IFN-γ/STAT1 signaling is 
not necessary for early expression of T-bet. Furthermore, 
there is some evidence that even endogenous STAT4 can 
  induce some T-bet in the absence of STAT1 signaling. This 
said, T-bet expression is not robust in STAT1−/− cells 
  expressing only endogenous STAT4, especially under subop-
timal Th1 conditions, and STAT1−/− T cells are similar to 
T-bet−/− T cells in that they exhibit enhanced GATA-3 
  expression, presumably because of lack of suffi   cient T-bet. 
Collectively, then, the data suggest that in normal CD4+ 
T cells, T-bet expression is initiated by TCR signaling acting 
in concert with IL-12/ STAT4 signaling, but only reaches its 
full extent with subsequent IFN-γ/STAT1 signaling.
As a fi  nal point, it is worth noting that T cells retain the 
capacity to produce small amounts of IFN-γ in the absence 
of STAT4 (28), and under these circumstances other factors 
including T-bet may come into play as major transcription 
factors. In addition, STAT4-/STAT6-defi   cient T cells or 
STAT4-defi  cient T cells cultured in the presence of anti–
IL-4 produce more IFN-γ than STAT4-defi  cient T cells cul-
tured in the absence of anti–IL-4, although still far less than 
wild-type Th1 T cells (28). The latter observation is conso-
nant with the present fi  ndings in that it suggests that even in 
the absence of STAT4, GATA-3 is a negative regulator of 
IFN-γ production, hence the importance of T-bet regula-
tory function in this context.
In summary, these fi  ndings provide the basis of a modi-
fi  ed model of T cell diff  erentiation (see Fig. S2, available at 
http:// www. jem. org/ cgi/ content/ full/ jem. 20052165/ DC1).  
In this model, GATA-3 is assumed to be the central factor 
whose level/activity decides the fate of Th cell diff  erentia-
tion, not only through its capacity to induce Th2 cytokine 
production, but also through its capacity to block Th1 cyto-
kine production via down-regulation of STAT4 and (indi-
rectly) the IL-12Rβ2 chain. Thus, in the course of T cell 
diff  erentiation occurring in the presence of IL-12 and IL-4 
(the usual milieu of naive T cells), such Th1 diff  erentiation is 
attenuated because concomitant IL-4 induction of GATA-3 
suppresses STAT4 and IL-12Rβ2 chain expression. If, how-
ever, T-bet is also induced at suffi   cient levels, such GATA-3 
suppression is counteracted, permitting Th1 diff  erentiation to 
occur. This ability of T-bet to oppose the action of GATA-3 
is its most essential function in Th1 diff  erentiation rather than 
any ability of T-bet to directly aff  ect IFNG gene transcrip-
tion, as has been argued previously.
MATERIALS AND METHODS
Reagents and mice. Human recombinant IL-2 and anti–mouse IL-4 
(11B11) antibody were obtained from National Cancer Institute(NCI)/
NIH. Murine recombinant IL-12, IL-4, anti–mouse IL-12, and anti–mouse 
IFN-γ antibody were purchased from PeproTech. Anti–mouse IL-12Rβ2 JEM VOL. 203, March 20, 2006  765
ARTICLE
chain monoclonal antibody (PDL-HAM10B9) was prepared as described pre-
viously (15). T-bet−/−, T-bet+/−, and wild-type mice (C57BL/6 × 129/SvJ) 
on an F2 background were provided by H. Young (NCI/NIH, Frederick, 
MD) and were originally from L. Glimcher (Harvard School of Public 
Health, Boston, MA). STAT1−/− and BALB/c mice were purchased from 
The Jackson Laboratory. All animal experiments were performed under pro-
tocols approved by the Animal Care Branch of the NIAID, NIH.
Cell isolation, culture, and retroviral transduction. Whole CD4+ 
T cells from splenocytes were isolated by positive selection using anti–mouse 
CD4 microbeads (Miltenyi Biotec). Naive (CD4+/CD62Lhi) and memory 
(CD4+/CD62Llo) Th cells were purifi  ed by negative selection using the 
Mouse CD4+ T Cell Isolation kit followed by positive selection using 
anti–mouse CD62L microbeads (Miltenyi Biotec). Alternatively, naive 
CD4+ T cells in negatively selected CD4+ T cell populations were also 
  isolated by fl  ow cytometric sorting of CD44lo CD62Lhi cells. The purity of 
the naive CD4+ T cells obtained after the latter procedure was >99%. 
Whole or naive CD4+ T cells were stimulated with either Con A plus APC 
(30 Gy-irradiated splenocytes from wild-type mice) or with 5 μg/ml of 
plate-bound anti-CD3 and 1 μg/ml of soluble anti-CD28 under various 
T cell–polarizing conditions. For studies of intracellular cytokine produc-
tion, naive CD4+ T cells purifi  ed by anti-CD62L microbeads were stimu-
lated as described above under various T cell–polarizing conditions and 
expanded with IL-2 on days 2 and 4 of culture. On day 8, the cells were 
washed, restimulated with 20 ng/ml PMA and 1 μm ionomycin for 6 h, and 
then stained as indicated below. For studies of IFN-γ secretion, naive CD4+ 
T cells purifi  ed by cell sorting were stimulated with 5 μg/ml of plate-bound 
anti-CD3 and 1 μg/ml of soluble anti-CD28 under various T cell–polariz-
ing conditions. After 2 d, the cells were expanded for 4 d by culture in 
50 U/ml rhIL-2 in the continued presence of the above cytokines and anti-
bodies. On day 6, cells were washed and restimulated with either 5 μg/ml 
of plate-bound CD3 for 24 h or with PMA/ionomycin for 6 h. Cells were 
cultured at a concentration of 5 × 105 cells/ml during the initial culture and 
106 cells/ml during reculture. The amount of cytokines secreted into the 
culture supernatant was measured by ELISA.
Mouse Th2 clone D10.G4.1 (D10) cells were purchased from American 
Type Culture Collection and maintained by conalbumin/APC stimulation 
every 2 wk. cDNAs encoding murine STAT4, T-bet, and IL-12Rβ2 chain 
were cloned into pBMN-IRES-EGFP (provided by G. Nolan, Stanford 
University, Palo Alto, CA), and cells were transduced as described previ-
ously (16, 29).
Cytokine measurements. ELISAs for IL-4, IL-5, and IFN-γ were per-
formed using the OptEIA Mouse kit (BD Biosciences) according to the 
manufacturer’s protocol using a TMB Microwell (BioFX) system. Intracel-
lular cytokine staining was performed as described previously (30).
mRNA and Western blot analysis. Protein extraction and Western blot 
analysis were performed as described previously (16). Total RNA was iso-
lated with a STAT60 RNA isolation kit (Tel-Test, Inc.), treated with RQ1 
RNase–free DNase (Promega), and reverse transcribed. Real-time PCR was 
performed using ABI Prism 7700 Sequence BioDetector (PE Applied Bio-
systems) using ribosomal RNA as a control. The expression level of GATA-3 
mRNA was measured by ∆Ct method after justifying it by using serially di-
luted standard sample from D10 cells. The results were normalized to 
18S rRNA abundance and then unit was recalculated using standard GATA-3 
mRNA level of D10 cells, which was set at 800 units.
ChIP and DNase hypersensitivity analysis. ChIP assay was performed 
as described previously (31) according to the manufacturer’s instructions 
(Upstate Biotechnology). PCR was performed as described previously (29). 
PCR primers for the IFNG promoter were 5′-C  G  T  A  A  T  C  C  C  G  A  G  G  A  G  C-
C  T  T  C  -3′ and 5′-C  T  T  C  A  A  T  G  A  C  T  G  T  G  C  C  G  T  G  G  -3′. DNase I hyper-
sensitivity assay was performed as described by Agarwal et al. (32). In brief, 
nuclei were isolated from 4 × 107 cells, divided into eight aliquots, and incu-
bated with 0–63 U/ml DNase I (Roche) for 20 min at 37°C. DNA was puri-
fi  ed and digested with BamHI. Samples were resolved on a 0.8% agarose gel, 
transferred to Nyron membranes, and hybridized with an exon 4 probe from 
the IFN-γ locus. Hybridized membranes were exposed to imaging screens 
and analyzed by a phosphoimager (STORM 860; Molecular Dynamics).
Densitometry and statistical analysis. Band densities in the autoradio-
gram were scanned and measured using an NIH-Image (NIH), and statistical 
analysis was performed by Student’s t test.
Online supplemental material. Fig. S1 shows the expression of IL-12Rβ2 
in cells from T-bet−/− mice after stimulation under various Th1 and Th2 
conditions, and Fig. S2 shows a schematic diagram of Th1/Th2 diff  erentia-
tion based on the role of T-bet established in this study. Figs. S1 and S2 are 
available at http:// www. jem. org/ cgi/ content/ full/ jem. 20052165/ DC1.
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